Annovis Bio, Inc. (ANVS) — Total Liabilities
| Fiscal Year | Total Liabilities | Change YoY |
|---|---|---|
| 2025 | $4.23M | -8.4% |
| 2024 | $4.62M | -74.3% |
| 2023 | $17.96M | +133.3% |
| 2022 | $7.70M | +411.0% |
| 2021 | $1.51M | +160.5% |
| 2020 | $578.4K | -77.9% |
| 2019 | $2.62M | — |
| Fiscal Year | Total Liabilities | Change YoY |
|---|---|---|
| 2025 | $4.23M | -8.4% |
| 2024 | $4.62M | -74.3% |
| 2023 | $17.96M | +133.3% |
| 2022 | $7.70M | +411.0% |
| 2021 | $1.51M | +160.5% |
| 2020 | $578.4K | -77.9% |
| 2019 | $2.62M | — |